Briefcase Biotech has developed the Kilobaser, the world's first microfluidic chip and cartridge-based synthesizer for DNA and RNA. This innovative platform allows users to produce custom DNA and RNA on demand, significantly enhancing the speed and affordability of molecular synthesis. The Kilobaser utilizes a single-use microfluidic chip that integrates all essential functions of traditional automated synthesizers while minimizing waste and reagent consumption. With its advanced design, the Kilobaser can synthesize 300 picomoles of a sequence efficiently, making it a valuable tool for life science professionals engaged in molecular cloning and other applications.

The Kilobaser's reagent cartridge system further optimizes the synthesis process by housing enough reagents to create multiple nucleotides while maintaining a compact size. Each cartridge is designed to support the synthesis of up to 150 nucleotides, containing essential DNA or RNA bases and auxiliary reagents. This system not only reduces the complexity of ordering and delivery but also allows researchers to produce molecular tools directly at their lab benches, streamlining workflows and enhancing productivity. Overall, Briefcase Biotech's Kilobaser represents a significant advancement in the field of oligo synthesis, providing researchers with the independence and efficiency needed in modern molecular biology.

Austria

Kilobaser is a Biotechnology company that offers in-house DNA and RNA synthesis services with the Kilobaser DNA & RNA Synthesizer for fastest access to molecular tools, producing ready-to-use modified oligos on-demand.

Briefcase Biotech

Company Details